Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
暂无分享,去创建一个
G. Morgan | W. Gregory | M. Drayson | N. Russell | M. Jenner | F. Davies | G. Cook | G. Jackson | D. Cairns | M. Kaiser | R. Owen | M. Garg | C. Pawlyn | J. Lindsay | K. Karunanithi | John R. Jones | Cathy D. Williams | Anna Waterhouse | B. Kishore | C. Williams | A. Striha | C. Collett | Jamie N Wilson | G. Jackson | Corinne Collett | Alina Striha | Kamaraj Karunanithi | Jamie Wilson